Pharmerica Cash Flow - Quarterly (NYSE:PMC)

Add to My Stocks
$29.05 $0 (0%) PMC stock closing price Aug 16, 2017 (Closing)

For analyzing any company like Pharmerica from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Pharmerica profits one has to check the income statement and for Pharmerica debt one has to check the balance sheet. Pharmerica stock analysis shows positive net income cash flow of $8.2M for 2017-Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   Pharmerica saw a outflow of $10.5M from investing activities for 2017-Q2. View details of Pharmerica cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Pharmerica Net Income Cash Flow
8.2M3.5M21.6M13.9M6.6M4.1M35.1M14.9M11.9M9.6M
Depreciation Depletion Amortization Cash-Flow33.1M16.2M58.1M42.3M27.7M13.6M52.3M38.2M25.4M12.5M
Net Increase (Decrease) in Assets Liabilities61.3M47.09M-64.39M9.6M-5.1M40M-80.3M-3.69M-21.6M17.8M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net12.1M5.4M15.5M14.5M12M4.6M11.4M10.2M6.4M4.4M
Pharmerica Net Cash from (used by) Operating Activities
114.7M72.2M30.8M80.3M41.2M62.3M18.5M59.6M22.1M44.3M
Increase (Decrease) in Prop Plant And Equipment-15.9M-7.9M-34.1M-26.2M-13.3M-5.4M-23.8M-17.4M-11M-4.6M
Acquisition Disposition of Subsidiaires-50.7M-48.2M-57.6M-31.3M-6.9M-6.7M-83.6M-20.9M-20.5M-20.4M
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities------3.3M---
Pharmerica Net Cash from (used by) Invesment Activities
-66.6M-56.1M-91.7M-57.5M-20.2M-12.1M-104.1M-38.3M-31.5M-25M
Issuance (Purchase) of Equity Shares0.8M0.8M-3.1M-3.1M-2.9M-2.9M-3.5M-3.6M-3.2M-4.1M
Issuance (Repayment) of Debt Securities-40.8M-6.9M46.8M-36.3M-5.8M-47.9M76.5M-13.3M-0.5M-0.2M
Increase (Decrease) in Bank & Other Borrowings-----8M----1M-25M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.5M--3M2.4M2.3M2.1M1.9M
Pharmerica Net Cash from (used by) Financing Activities
-40M-6.1M43.2M-39.4M-16.7M-47.8M75.4M-14.6M-2.6M-27.4M
Effect of Exchange Rate Changes on Cash----------
Pharmerica Net Change in Cash & Cash Equivalents
8.1M10M-17.7M-16.6M4.3M2.4M-10.2M6.7M-12M-8.1M
Cash & Equivalents at Beginning of Year23.1M33.3M24.2M12.3M17.4M10.8M51.2M41.3M32M3.7M
Cash & Equivalents at Year End13.5M15.4M5.4M6.5M27.4M25.5M23.1M40M21.3M25.2M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

1:29
PMC
Pharmerica stock comparison chart provides an easy way to compare the stock price with peers along with details of Pharmerica stock price history.
The statement of cash flows can be categorized into three main sections:
  • Pharmerica has cash of $13.5M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Pharmerica stock price.
  • The cash generated from the core business or operations was positive at $114.7M for Pharmerica in the latest quarter. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-66.6M for PMC stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Pharmerica and its owners and creditors and was $-40M for 2017-Q2. Financing activities allow a company to raise capital, and repay bondholders.
.

Key Financial Ratios For Pharmerica Cash Flow

FCF margin
0.06